Development of dividable one-step dry-coated tablets (dividable-OSDRC) and their evaluation as a new platform for controlled drug release

Pharmaceutical Research

Volumn 21, Issue 7, 2004, Pages 1177-1183

  Ozeki, Yuichi ^a   Watanabe, Yukinao ^a   Okamoto, Hirokazu ^b   Danjo, Kazumi ^b  

^a SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

compression coated tablets; controlled release; dividable OSDRC; one step dry coated tablets

Indexed keywords

ALPHA LACTOSE; CARBOXYMETHYLCELLULOSE; CITRIC ACID TRIETHYL ESTER; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN DERIVATIVE; MAGNESIUM STEARATE; NEUSILIN US 2; PARACETAMOL; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL PROCEDURES; COMPRESSION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG COATING; DRUG HALF LIFE; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STRUCTURE; EVALUATION; PRESSURE; PRIORITY JOURNAL; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; TABLET; WEIGHT;

ACETAMINOPHEN; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EXCIPIENTS; KINETICS; METHYLCELLULOSE; SOLUBILITY; TABLETS, ENTERIC-COATED; TIME FACTORS;

EID: 3242685316     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000033004.88953.bc     Document Type: Article

References (23)

1. E. Fukui, K. Uemura, and M. Kobayashi. Studies on applicability of press-coated tables using hydroxpropylcellulose (HPC) in the outer shell for time-release preparations. J. Control. Rel. 68:215-223 (2000).
2. E. Fukui, N. Miyamuro, T. Yoneyama, and M. Kobayashi. Drug release form and mechanical properties of press-coated tablets with hydroxpropylmethylcellulose acetate succinate and plasticizers in the outer shell. Int. J. Pharm. 217:33-43 (2001).
3. K. Tahara, K. Yamamoto, and T. Nishihata. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J. Control. Rel. 35:59-66 (1995).
4. R. Ishino, H. Yoshino, Y. Hirakawa, and K. Noda. Design and preparation of pulsatile release tablet as a new oral drug delivery system. Chem. Pharm. Bull. 40:3036-2041 (1992).
5. R. Ishino, H. Yoshino, Y. Hirakawa, and K. Noda. Absorption of diltiazem in beagle dog from pulsatile release tablet. Chem. Pharm. Bull. 40:3094-3096 (1992).
6. I. S. Moussa and L. H. Cartilier. Evaluation of cross-linked amylose press-coated tablets for sustained drug delivery. Int. J. Pharm. 149:139-149 (1997).
7. M. Matuo, C. Nakamura, K. Arimori, and M. Nakano. Evaluation of hydroxyeylcelulose as a hydrophilic swellable material for delayed-release tablets. Chem. Pharm. Bull. 43:311-314 (1995).
8. M. P. Danckwerts and J. G. Watt. The effect of processing variables on the compression properties of controlled release core-in-cup compressed tablets from a new adjustable punch. Int. J. Pharm. 123:85-94 (1995).
9. H. Takeuchi, T. Yasuji, H. Yamamoto, and Y. Kawashima. Spry-dryied lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated having a time controlled-releasing function. Pharm. Res. 17:94-99 (2000).
10. E. van Santen, D. M. Barends, and H. W. Frijlink. Breaking of scored tablets: a review. Eur. J. Pharm. Biopharm. 53:139-145 (2002).
11. T. Makino, S. Imoto, Y. Mizukami, S. Marunaka, J. Kikuta, S. Hirai, and N. Kitamori. Design and evaluation of scored tablets. Jpn. J. Hosp. Pharm. 19:280-286 (1993).
12. J. McEwen, C. Durnin, M. E. T. McMurdo, and T. A. Moreland. Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120-mg and 240-mg tables and the effect of having a 240-mg tablet. J. Cardiovasc. Pharmacol. 13:S57-S59 (1989).
13. A. Stockis, S. D. Bruyn, X. Deroubaix, B. Jeanbaptiste, E. Lebacq Jr., F. Nollevaux, G. Poli, and D. Acerbi. Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab®). Eur. J. Pharm. Biopharm. 53:49-56 (2002).
14. H. A. Lieberman and L. Lachman. Pharmaceutical Dosage Forms: Tablets, Vol. 1. Marcel Dekker, New York, 1980, pp. 187-224.
15. Y. Ozeki, Y. Kondo, and Y. Watanabe. Nucleated molded article, method of producing the same, and device for producing the same. Published applications for patent. PCT WO01/98067, 27 Dec. 2001.
16. Y. Ozeki, Y. Kondo, Y. Watanabe, K. Shimada, and K. Harada. Rotary type compression molding machine. Published applications for patent. PCT WO02/90098, 14 Nov. 2002.
17. Y. Ozeki, Y. Watanabe, S. Inoue, and K. Danjo. Comparison of the compression characteristics between new one-step dry-coated tablets (OSDRC) and dry-coated tablets (DC). Int. J. Pharm. 259:69-77 (2003).
18. Y. Ozeki, Y. Watanabe, S. Inoue, and K. Danjo. Evaluation of the compression characteristics and physical properties of the newly invented one-step dry-coated tablets (OSDRC). Int. J. Pharm. 267:69-78 (2003).
19. Y. Ozeki, Y. Kondo, and Y. Watanabe. Multi-cored molded article, method of producing the same, and device for producing the same. Published applications for patent, PCT WO03/026560, 3 Apr. 2003.
20. J. W. Moore and H. H. Flanner. Mathematical comparison of dissolution profiles. Pharm. Tech. 20:64-74 (1996).
21. J. E. Polli, G. S. Rekhi, L. L. Augsburger, and V. P. Shah. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 86:690-700 (1997).
22. 2. Pharm. Res. 15:889-896 (1998).
23. U.S. Department of Health and Human Services. Food and Drug Administration. Center of Drug Evaluation and Research (CDER) Guidance for Industry; Dissolution testing of immediate release solid oral dosage forms, August 1997. http: //www.fda.gov/cder/guidance.htm.